Drug intelligence / Profile preview

Chen's Tangshen Formula

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Chen's Tangshen Formula (陈氏糖肾方) is a proprietary traditional Chinese medicine (TCM) compound formula developed for the treatment of diabetic kidney disease (DKD), also known as diabetic nephropathy. The formula is based on TCM principles, with reported effects of "tonifying qi and nourishing yin, activating blood circulation, and resolving stasis." Clinical studies indicate that it can improve renal function in patients with DKD, particularly when initiated in early stages of the disease[3][9]. Mechanistic research suggests that its pharmacological actions include anti-inflammatory effects, antioxidative stress reduction, inhibition of fibrosis and lipid deposition in the kidney, and suppression of pyroptosis via modulation of the TXNIP-NLRP3-GSDMD axis. This results in reduced proteinuria and improved renal pathology[5]. The formula is used orally as a decoction or granule preparation.

Brand names
Chen's Tangshen Recipe
Other names
陈氏糖肾方
02

Targets

GSDMD (Gasdermin D)TXNIP (Thioredoxin-interacting protein)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Chen's Tangshen Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chen's Tangshen Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call